Quick Answer
Teladoc Health, Inc. reported Cash and Equivalents of $781.08 million for fiscal year 2025.
Teladoc Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $781.08M | -39.8% |
| 2024 | $1.30B | +15.5% |
| 2023 | $1.12B | +22.4% |
| 2022 | $918.18M | +2.8% |
| 2021 | $893.48M | +21.8% |
| 2020 | $733.32M | +42.6% |
| 2019 | $514.35M | +21.3% |
| 2018 | $423.99M | +890.2% |
| 2017 | $42.82M | -14.4% |
| 2016 | $50.02M | -9.2% |
| 2015 | $55.07M | +18.6% |
| 2014 | $46.44M | +1345.7% |
| 2013 | $3.21M | -63.1% |
| 2012 | $8.69M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $726.25M | -41.6% | +6.9% |
| June 30, 2025 | $679.62M | -41.5% | -43.0% |
| March 31, 2025 | $1.19B | +8.7% | -8.1% |
| December 31, 2024 | $1.30B | +15.5% | +4.4% |
| September 30, 2024 | $1.24B | +20.7% | +7.0% |
| June 30, 2024 | $1.16B | +21.2% | +5.9% |
| March 31, 2024 | $1.10B | +23.6% | -2.3% |
| December 31, 2023 | $1.12B | +22.4% | +9.0% |
- Teladoc Health, Inc. showed a decrease of -39.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, Teladoc Health, Inc.’s cash and equivalents has grown by 8884.2% (from $8.69 million to $781.08 million).
- The most recent figure is from Teladoc Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: